US 11,911,478 B2
Liquid compositions
Gerard P. McNally, Derwyn, PA (US); Anurag Pandey, Lower Gwynedd, PA (US); and Vipul Dave, Hillsborough, NJ (US)
Assigned to Johnson & Johnson Consumer Inc., Skillman, NJ (US)
Filed by Johnson & Johnson Consumer Inc., Skillman, NJ (US)
Filed on Dec. 7, 2020, as Appl. No. 17/114,104.
Application 17/114,104 is a continuation of application No. 15/824,301, filed on Nov. 28, 2017, granted, now 10,888,620.
Claims priority of provisional application 62/427,080, filed on Nov. 28, 2016.
Prior Publication US 2021/0093723 A1, Apr. 1, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 47/38 (2006.01); A61P 11/14 (2006.01); A61P 11/04 (2006.01); A61K 9/08 (2006.01); A61K 47/10 (2017.01); A61K 47/34 (2017.01); A61P 11/00 (2006.01); A61K 31/09 (2006.01); A61K 31/137 (2006.01); A61K 31/167 (2006.01); A61K 31/192 (2006.01); A61K 31/485 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01)
CPC A61K 47/38 (2013.01) [A61K 9/08 (2013.01); A61K 31/09 (2013.01); A61K 31/137 (2013.01); A61K 31/167 (2013.01); A61K 31/192 (2013.01); A61K 31/485 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61K 47/34 (2013.01); A61P 11/00 (2018.01); A61P 11/04 (2018.01); A61P 11/14 (2018.01)] 16 Claims
 
1. A liquid composition for treating cough cold symptoms, wherein said liquid composition comprises between about 0.1% and 3.0% of a muco-adhesive material, wherein said liquid composition has a traction coefficient of less than about 0.01 at 1-15 mm/sec rolling speed at 37°, using a slide roll ratio (SRR) of 50% at 2 N normal load and wherein the liquid composition further comprises from about 0.1% to about 2% of a surfactant selected from the group consisting of poloxamer 118, poloxamer 407 and polyoxyethylene (20) sorbitan monooleate.